BR112013033444A2 - formulações para terapia de ferida - Google Patents
formulações para terapia de feridaInfo
- Publication number
- BR112013033444A2 BR112013033444A2 BR112013033444A BR112013033444A BR112013033444A2 BR 112013033444 A2 BR112013033444 A2 BR 112013033444A2 BR 112013033444 A BR112013033444 A BR 112013033444A BR 112013033444 A BR112013033444 A BR 112013033444A BR 112013033444 A2 BR112013033444 A2 BR 112013033444A2
- Authority
- BR
- Brazil
- Prior art keywords
- wound therapy
- therapy formulations
- formulations
- wound
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0042—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0085—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/009—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11172945 | 2011-07-06 | ||
PCT/EP2012/063330 WO2013004838A1 (en) | 2011-07-06 | 2012-07-06 | Formulations for wound therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013033444A2 true BR112013033444A2 (pt) | 2017-01-31 |
Family
ID=46466555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013033444A BR112013033444A2 (pt) | 2011-07-06 | 2012-07-06 | formulações para terapia de ferida |
Country Status (10)
Country | Link |
---|---|
US (2) | US9717821B2 (pt) |
EP (1) | EP2729129A1 (pt) |
JP (1) | JP2014518250A (pt) |
KR (1) | KR20140041709A (pt) |
CN (1) | CN103717208A (pt) |
AU (1) | AU2012280218B2 (pt) |
BR (1) | BR112013033444A2 (pt) |
CA (1) | CA2840905A1 (pt) |
RU (1) | RU2013155713A (pt) |
WO (1) | WO2013004838A1 (pt) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102012002209A1 (de) * | 2012-02-07 | 2013-08-08 | Carl Freudenberg Kg | Biodegradierbares Vlies für medizinische Zwecke |
RU2657955C2 (ru) | 2012-03-06 | 2018-06-18 | Ферросан Медикал Дивайсиз А/С | Контейнер под давлением, содержащий гемостатическую пасту |
BR112014030962A2 (pt) | 2012-06-12 | 2017-06-27 | Ferrosan Medical Devices As | métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático |
CN105188740A (zh) * | 2013-03-07 | 2015-12-23 | 普罗菲布里克有限公司 | 包含凝血酶和纤维蛋白原的粉末制剂 |
DE102013203997A1 (de) * | 2013-03-08 | 2014-09-11 | Aesculap Ag | Medizinisches Produkt |
DK2968214T3 (da) | 2013-03-15 | 2021-06-07 | Newvapogen Inc | Hidtil ukendte analgetiske sammensætninger |
JP2014221012A (ja) * | 2013-05-13 | 2014-11-27 | 清水建設株式会社 | 模擬粉体、粉体飛散状態評価方法、及び粉体取扱い施設 |
JP6143078B2 (ja) * | 2013-05-13 | 2017-06-07 | 清水建設株式会社 | 模擬粉体の製造方法、及び粉体飛散状態評価方法 |
US10765774B2 (en) | 2013-07-09 | 2020-09-08 | Ethicon, Inc. | Hemostatic pad assembly kit and method |
EP3470094B1 (en) | 2013-12-11 | 2020-07-22 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
EP3082866A4 (en) * | 2013-12-16 | 2017-06-14 | The University Of British Columbia | Self-fueled particles for propulsion through flowing aqueous fluids |
KR101864465B1 (ko) * | 2014-01-21 | 2018-06-04 | 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 | 의료용 도관을 통한 생체 내 투여성 마이크로 입자 |
KR101649792B1 (ko) * | 2014-07-16 | 2016-08-22 | 주식회사 제네웰 | 비압박 지혈용 고분자 폼 제조용 조성물, 이를 이용한 비압박 지혈용 고분자 폼의 제조방법 및 비압박 지혈 팩킹용 고분자 폼 |
CA2960309A1 (en) * | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
WO2016178829A1 (en) * | 2015-05-06 | 2016-11-10 | Gyrus Acmi, Inc. (D.B.A. Olympus Surgical Technologies America) | Carboxymethyl chitosan sponge formulation |
US10751444B2 (en) | 2015-08-07 | 2020-08-25 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
US10660945B2 (en) | 2015-08-07 | 2020-05-26 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
KR20170025011A (ko) * | 2015-08-27 | 2017-03-08 | 고려대학교 산학협력단 | 통증완화약물의 지속성 방출을 위한 약학적 조성물 및 그 투여를 위한 투여 장치 |
CN108495658B (zh) * | 2015-09-01 | 2021-09-03 | 巴克斯特国际公司 | 止血材料 |
BR112018008895B1 (pt) | 2015-11-06 | 2021-11-16 | Ethicon, Inc. | Agregados hemostáticos e método para sua produção |
DE102015226456A1 (de) * | 2015-12-22 | 2017-06-22 | Heraeus Medical Gmbh | Verfahren zur Sterilisation von wässrigen Polysaccharidlösungen und sterile wässrige Polysaccharidlösungen |
US10258337B2 (en) | 2016-04-20 | 2019-04-16 | Ethicon Llc | Surgical staple cartridge with severed tissue edge adjunct |
CA3023800A1 (en) * | 2016-05-13 | 2017-11-16 | Merck Patent Gmbh | Hot melt extrusion composition using direct compressible excipient as plasticizer |
CN107485728A (zh) * | 2016-06-12 | 2017-12-19 | 胡庆柳 | 一种胶原纤维蛋白复合止血贴及其制备方法 |
WO2018005145A1 (en) * | 2016-06-28 | 2018-01-04 | Victor Matthew Phillips | Flowable hemostatic gel composition and its methods of use |
EP3478234A4 (en) * | 2016-06-29 | 2020-02-26 | IVIEW Therapeutics, Inc. | INNOVATIVE COMPOSITIONS FOR SHAPING THIN FILMS WITH FAST DEPOSITION AS AN EFFECTIVE Wound Care Treatment |
CN107754005B (zh) | 2016-08-15 | 2021-06-15 | 广州倍绣生物技术有限公司 | 止血组合物及其制造方法 |
US11413335B2 (en) | 2018-02-13 | 2022-08-16 | Guangzhou Bioseal Biotech Co. Ltd | Hemostatic compositions and methods of making thereof |
AU2017328480A1 (en) * | 2016-09-14 | 2019-03-14 | Ethicon, Inc. | Stable pharmaceutical foam |
IL247810A0 (en) | 2016-09-14 | 2017-01-31 | Omrix Biopharmaceuticals Ltd | Stable pharmaceutical foam |
WO2018067628A1 (en) * | 2016-10-05 | 2018-04-12 | 3M Innovative Properties Company | Fibrin composition comprising carrier material, method and wound articles |
CN106620660A (zh) * | 2016-12-30 | 2017-05-10 | 深圳市新指南医学科技发展有限公司 | 一种止血喷雾剂 |
CN110621286A (zh) * | 2017-02-23 | 2019-12-27 | 阿里拉健康波士顿有限责任公司 | 生态友好型破坏生物膜的抗微生物制剂、其开发及用途 |
RU2652270C1 (ru) * | 2017-05-24 | 2018-04-25 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) | Гемостатический раствор на основе сульфатированных полисахаридов и получение гемостатических губок из этого раствора (варианты) |
RU2662144C1 (ru) * | 2017-06-26 | 2018-07-23 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) | Способ остановки кровотечения при оружейных ранениях паренхиматозных органов брюшной полости |
US11007299B2 (en) | 2017-11-08 | 2021-05-18 | Ethicon, Inc. | Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery |
JP7129324B2 (ja) | 2017-12-15 | 2022-09-01 | 株式会社イノアックコーポレーション | ポリウレタンフォームの製造方法 |
WO2019117292A1 (ja) * | 2017-12-15 | 2019-06-20 | 株式会社イノアックコーポレーション | ポリウレタンフォームの製造方法 |
SG11202005231RA (en) * | 2017-12-29 | 2020-07-29 | Baxter Int | Spray-dried thrombin and methods of using and making spray-dried thrombin |
US10786596B2 (en) | 2018-01-12 | 2020-09-29 | Boston Scientific Scimed, Inc. | Powder for achieving hemostasis |
AU2019221631B2 (en) * | 2018-02-15 | 2023-12-07 | Dilon Technologies Inc. | Multi-dimensional hemostatic product and method for producing the same |
US10980913B2 (en) | 2018-03-05 | 2021-04-20 | Ethicon Llc | Sealant foam compositions for lung applications |
WO2019215274A1 (en) * | 2018-05-09 | 2019-11-14 | Ferrosan Medical Devices A/S | Method for preparing a haemostatic composition |
CN108553481B (zh) * | 2018-05-25 | 2020-11-13 | 中国海洋大学 | 一种具有促进伤口愈合作用的糖类组合物及其应用 |
CN111249516B (zh) * | 2018-12-01 | 2020-12-22 | 浙江大学 | 一种含胰蛋白酶的止血织物及其制备方法 |
CN109646707A (zh) * | 2018-12-14 | 2019-04-19 | 广州润虹医药科技股份有限公司 | 一种快速止血材料及其制备方法 |
WO2020122007A1 (ja) * | 2018-12-14 | 2020-06-18 | 株式会社ビーエムジー | 2反応剤型のシート状組織接着補強材 |
CN111035799A (zh) * | 2019-01-02 | 2020-04-21 | 浙江西安交通大学研究院 | 用于获得自推式发泡组织密封胶的自推进颗粒及其制备方法 |
US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
US20220023491A1 (en) * | 2020-07-21 | 2022-01-27 | Ethicon, Inc. | Hemostatic Composite Aggregate Materials Having Surface Enriched with Hemostatis |
CN112972755B (zh) * | 2021-03-25 | 2022-07-05 | 哈尔滨瀚邦医疗科技有限公司 | 一种基于猪源纤维蛋白原和凝血酶的生物止血材料的制备方法 |
WO2023007435A2 (en) * | 2021-07-28 | 2023-02-02 | Savitribai Phule Pune University | Method for producing biodegradable polymeric films from biomass waste |
CA3224328A1 (en) * | 2021-08-13 | 2023-02-16 | Biotest Ag | Fibrinogen compositions and methods of preparation |
CN113925997B (zh) * | 2021-10-13 | 2022-12-06 | 深圳市华宝生物材料科技有限公司 | 一种含止血微胶囊的明胶海绵及其制备方法 |
WO2023115427A1 (en) | 2021-12-23 | 2023-06-29 | Guangzhou Bioseal Biotech Co., Ltd. | Spray dried thrombin |
US11642324B1 (en) | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
KR102475934B1 (ko) * | 2022-03-17 | 2022-12-08 | 구태훈 | 카복시메틸 키토산과 히알루론산 또는 그 유도체 및 트롬빈을 포함하는 흡수성 지혈 스펀지 패드, 및 그 제조방법 |
WO2024068836A1 (en) * | 2022-09-30 | 2024-04-04 | Ferrosan Medical Devices A/S | Haemostatic composition |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3105624A1 (de) | 1981-02-16 | 1982-09-02 | Hormon-Chemie München GmbH, 8000 München | Material zum abdichten und heilen von wunden |
DE3214337C2 (de) | 1982-04-19 | 1984-04-26 | Serapharm - Michael Stroetmann, 4400 Münster | Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung |
US4752466A (en) | 1987-08-31 | 1988-06-21 | Johnson & Johnson Products, Inc. | Thrombin aerosol |
US7196054B1 (en) | 1990-11-27 | 2007-03-27 | The American National Red Cross | Methods for treating wound tissue and forming a supplemented fibrin matrix |
GB9107628D0 (en) | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
KR970705979A (ko) | 1994-09-29 | 1997-11-03 | 디 히스 | 치료용 매개체로서의 분무-건조 미소입자 (Spray-dried microparticles as therapeutic vehicles) |
PT796090E (pt) | 1994-12-16 | 2003-07-31 | Elan Drug Delivery Ltd | Microparticulas reticuladas e sua utilizacao como veiculos terapeuticos |
EP0914096B1 (en) * | 1996-05-17 | 2003-08-13 | Elan Drug Delivery Limited | Microparticles and their use in wound therapy |
US5839730A (en) | 1996-05-22 | 1998-11-24 | Shuffle Master, Inc. | Consecutive card side bet method |
US6762336B1 (en) | 1998-01-19 | 2004-07-13 | The American National Red Cross | Hemostatic sandwich bandage |
US6451349B1 (en) | 1998-08-19 | 2002-09-17 | Quadrant Healthcare (Uk) Limited | Spray-drying process for the preparation of microparticles |
KR100804434B1 (ko) | 1998-12-23 | 2008-02-20 | 체에스엘 베링 게엠베하 | 피브린계 접착제 과립 및 이의 제조방법 |
US7572769B2 (en) | 1998-12-23 | 2009-08-11 | Csl Behring Gmbh | Fibrin adhesive granulate and method for its preparation |
CA2434964C (en) * | 2001-01-25 | 2009-04-21 | Nycomed Pharma As | Carrier with solid fibrinogen and solid thrombin |
US7052713B2 (en) | 2001-02-13 | 2006-05-30 | Nycomed Pharma As | Carrier with solid fibrinogen and solid thrombin |
DE60227691D1 (de) | 2001-11-01 | 2008-08-28 | Nektar Therapeutics | Sprühtrocknungsverfahren |
FR2900054B1 (fr) | 2006-04-21 | 2012-09-28 | Kitozyme Sa | Utilisation de polysaccharides d'origine fongique comme composition pharmaceutique ou complements alimentaires pour la sante humaine et animale |
DK1581268T3 (da) | 2003-01-09 | 2011-08-15 | Polyganics Bv | Biomedicinske skum |
DE602004018363D1 (de) | 2003-10-27 | 2009-01-22 | Vertex Pharma | Kombinationen für die hcv-behandlung |
CN101516301B (zh) * | 2006-08-04 | 2014-10-15 | Stb有限公司 | 用于处理受伤组织的固体敷料 |
WO2010002435A2 (en) * | 2008-07-03 | 2010-01-07 | Kulinets Irina B | Hemostatic pouch and method to stabilize hemostatic components |
AU2009268052B2 (en) | 2008-07-09 | 2015-05-28 | Mallinckrodt Pharma Ip Trading D.A.C. | Recombinant fibrinogen |
WO2010142507A2 (en) | 2009-05-13 | 2010-12-16 | Kitozyme S.A. | Adhesive composition |
NL2002931C2 (en) | 2009-05-27 | 2010-11-30 | Polyganics Bv | HEMOSTATIC FOAMS. |
PL2435028T3 (pl) * | 2009-05-28 | 2017-09-29 | Profibrix Bv | Uszczelniacz fibrynowy w postaci suchego proszku |
GB0909136D0 (en) * | 2009-05-28 | 2009-07-01 | Profibrix Bv | Dry powder composition |
-
2012
- 2012-06-06 RU RU2013155713/15A patent/RU2013155713A/ru not_active Application Discontinuation
- 2012-07-06 WO PCT/EP2012/063330 patent/WO2013004838A1/en active Application Filing
- 2012-07-06 AU AU2012280218A patent/AU2012280218B2/en not_active Ceased
- 2012-07-06 EP EP12733135.3A patent/EP2729129A1/en not_active Withdrawn
- 2012-07-06 CA CA2840905A patent/CA2840905A1/en not_active Abandoned
- 2012-07-06 CN CN201280033664.7A patent/CN103717208A/zh active Pending
- 2012-07-06 JP JP2014517836A patent/JP2014518250A/ja active Pending
- 2012-07-06 BR BR112013033444A patent/BR112013033444A2/pt not_active Application Discontinuation
- 2012-07-06 US US14/131,012 patent/US9717821B2/en not_active Expired - Fee Related
- 2012-07-06 KR KR1020147000676A patent/KR20140041709A/ko not_active Application Discontinuation
-
2017
- 2017-06-26 US US15/633,017 patent/US20170304483A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2012280218B2 (en) | 2017-01-19 |
RU2013155713A (ru) | 2015-08-20 |
US9717821B2 (en) | 2017-08-01 |
CA2840905A1 (en) | 2013-01-10 |
AU2012280218A1 (en) | 2014-01-16 |
EP2729129A1 (en) | 2014-05-14 |
KR20140041709A (ko) | 2014-04-04 |
US20140369991A1 (en) | 2014-12-18 |
JP2014518250A (ja) | 2014-07-28 |
CN103717208A (zh) | 2014-04-09 |
US20170304483A1 (en) | 2017-10-26 |
WO2013004838A1 (en) | 2013-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013033444A2 (pt) | formulações para terapia de ferida | |
CO6801645A2 (es) | Nuevos inmunoconjugados | |
BR112014005914A2 (pt) | Produto para cicatrização de feridas tecidulares | |
DK3336082T3 (da) | Spaltelige lipider | |
DK3091029T3 (da) | Anti-IL13-antistofformuleringer | |
BR112013032887A2 (pt) | cateter | |
FI20116181A (fi) | Uusia terapeuttisia vektoreita | |
CR20140119A (es) | Composición y apósito para tratamiento de heridas | |
BR112013021783A2 (pt) | sutiã para tratamento com radiação | |
DK2760886T3 (da) | Immunocytokin-kombinationsterapi | |
DK2730310T3 (da) | Applikator | |
BR112013033974A2 (pt) | terapia de combinação | |
BR112014004908A2 (pt) | aparelho para higienizar dispositivo médicos | |
FI20115876A0 (fi) | Yhdistelmähoito | |
CO6870048A2 (es) | Formulación herbicida mejorada | |
CO6940426A2 (es) | Formulaciones farmacéuticas | |
BR112014000015A2 (pt) | formulação | |
BR112014005756A2 (pt) | vacina | |
CO6940380A2 (es) | Espray para heridas | |
BR112014002830A2 (pt) | fotossensibilizador para uso terapêutico | |
BR302013000341S1 (pt) | Configuração aplicada em aplicador para cosméticos | |
CO6880064A2 (es) | Métodos terapéuticos | |
BR112014000021A2 (pt) | terapia direcionada para egfr | |
FI20115640A0 (fi) | Yhdistelmähoito | |
BR112013015731A2 (pt) | enrolamento de transformador |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: MALLINCKRODT PHARMA IP TRADING D.A.C. (IE) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |